Ziyi Chen, head of Asia Healthcare Research at Goldman Sachs, explains why China's biotech companies are becoming ...

China-based genome analysis firm Novogene established a wholly owned subsidiary, Novogene Korea, in June, marking its formal ...

The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way from their copycat days to challenge Western dominance on innovation.Most Read from ...

Chinese biotech Mabgeek Biotechnology has filed to go public in Hong Kong, seeking to raise funds to support development of ...

Aphranel, China's leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best ...

BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China's rapid rise in biotechnology, especially for drug and agricultural development ...

China Biotechnology Markets Report 2018: Historical Data 2007, 2012 & 2017 and Long Term Forecasts to 2022 & 2027 - ResearchAndMarkets.com ...